Related Experiment Video
Updated: Jul 10, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Current challenges in coronary stenting: from bench to bedside.
A C Morton1, R D Walker, J Gunn
1Cardiovascular Research Unit, Department of Medicine and Biomedical Science, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, U.K. a.c.morton@sheffield.ac.uk
Biochemical Society Transactions
|October 25, 2007
Summary
Percutaneous coronary intervention (PCI) is now more common than coronary artery bypass grafting (CABG) for heart disease. This review covers restenosis challenges, treatments, and future therapies for interventional cardiologists.
Area of Science:
- Interventional Cardiology
- Cardiovascular Disease Research
- Medical Device Technology
Background:
- Percutaneous coronary intervention (PCI) now exceeds coronary artery bypass grafting (CABG) in treating coronary heart disease.
- Interventional cardiology faces ongoing challenges in managing complex coronary artery lesions.
- Restenosis remains a significant complication following PCI procedures.
Purpose of the Study:
- To review current challenges in percutaneous coronary intervention (PCI).
- To discuss treatment options and future therapies for restenosis.
- To explore the impact of stent geometry and strategies for complex lesions.
Main Methods:
- Literature review of current interventional cardiology practices.
- Analysis of restenosis mechanisms and therapeutic approaches.
- Discussion of advanced techniques for challenging lesion subsets.
Main Results:
- PCI is the predominant revascularization strategy, surpassing CABG.
- Restenosis and complex lesion management (bifurcations, left main) are key clinical hurdles.
- Stent design and novel therapies show promise for improving outcomes.
Conclusions:
- Addressing restenosis and complex lesions is crucial for optimizing PCI.
- Future research should focus on innovative stent technologies and therapeutic strategies.
- Continued advancements are needed to enhance the long-term efficacy of PCI.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...